Ana Pardo–Saganta

2.1k total citations · 1 hit paper
31 papers, 1.4k citations indexed

About

Ana Pardo–Saganta is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ana Pardo–Saganta has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Ana Pardo–Saganta's work include Neonatal Respiratory Health Research (7 papers), Acute Myeloid Leukemia Research (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Ana Pardo–Saganta is often cited by papers focused on Neonatal Respiratory Health Research (7 papers), Acute Myeloid Leukemia Research (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Ana Pardo–Saganta collaborates with scholars based in Spain, United States and Germany. Ana Pardo–Saganta's co-authors include Jayaraj Rajagopal, Brandon M. Law, Purushothama Rao Tata, Rui Zhao, Hongmei Mou, Vladimir Vinarsky, Borja Sáez, Benjamin D. Medoff, Sylvie Breton and Amar Sahay and has published in prestigious journals such as Nature, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

Ana Pardo–Saganta

29 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dedifferentiation of committed epithelial cells into stem cells in vivo

2013 499 citations Purushothama Rao Tata, Hongmei Mou et al. Nature profile →

Peers

Countries citing papers authored by Ana Pardo–Saganta

Since Specialization

Citations

This map shows the geographic impact of Ana Pardo–Saganta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Pardo–Saganta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Pardo–Saganta more than expected).

Fields of papers citing papers by Ana Pardo–Saganta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Pardo–Saganta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Pardo–Saganta. The network helps show where Ana Pardo–Saganta may publish in the future.

Co-authorship network of co-authors of Ana Pardo–Saganta

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Pardo–Saganta. A scholar is included among the top collaborators of Ana Pardo–Saganta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Pardo–Saganta. Ana Pardo–Saganta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Notch3 Pathway in Organ Fibrosis 2024 ·(unknown), (unknown), Borja Sáez, Ana Pardo–Saganta	0
2	Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B 2024 ·JCI Insight ·Hope A. Flaxman, (unknown), Hongwei Han, (unknown), (unknown), Chia‐Fu Chang, (unknown), Katharine E. Black, Andreas Weigert, Rajkumar Savai, (unknown), Ana Pardo–Saganta, David Lagares, Christina M. Woo	4
3	The 4A classification for patients with tricuspid regurgitation 2023 ·Revista Española de Cardiología (English Edition) ·(unknown), (unknown), Rocío Hinojar, Juan Manuel Monteagudo Ruiz, Ana Maria Garcı́a, (unknown), (unknown), Ángel Sánchez‐Recalde, Luisa Salido Tahoces, Ana Pardo–Saganta, José Luís Zamorano	4
4	170P Clonal hematopoiesis in asymptomatic individuals enrolled in a lung cancer screening program 2022 ·Annals of Oncology ·Luis M. Montuenga, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ana Pardo–Saganta, Marı́a José Calasanz, Javier J. Zulueta, Felipe Prósper, Rubén Pı́o	1
5	Notch3 Deficiency Attenuates Pulmonary Fibrosis and Impedes Lung-Function Decline 2021 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Isabel A. Calvo, (unknown), Clemens Ruppert, Javier J. Zulueta, Felipe Prósper, Borja Sáez, Ana Pardo–Saganta	29
6	CARMA3 Mediates Allergic Lung Inflammation in Response to Alternaria alternata 2018 ·American Journal of Respiratory Cell and Molecular Biology ·Benjamin Causton, Ana Pardo–Saganta, Jacob E. Gillis, (unknown), Tristan Kooistra, Jayaraj Rajagopal, Ramnik J. Xavier, (unknown), Benjamin D. Medoff	17
7	New Atlanta Classification of acute pancreatitis in intensive care unit: Complications and prognosis 2016 ·European Journal of Internal Medicine ·María‐Consuelo Pintado, (unknown), (unknown), (unknown), Ana Pardo–Saganta, Aaron Blandino Ortíz, Raúl de Pablo	17
8	Injury Induces Direct Lineage Segregation of Functionally Distinct Airway Basal Stem/Progenitor Cell Subpopulations 2015 ·Cell stem cell ·Ana Pardo–Saganta, Brandon M. Law, Purushothama Rao Tata, Jorge Villoria, Borja Sáez, Hongmei Mou, Rui Zhao, Jayaraj Rajagopal	151
9	Parent stem cells can serve as niches for their daughter cells 2015 ·Nature ·Ana Pardo–Saganta, Purushothama Rao Tata, Brandon M. Law, Borja Sáez, Ryan D. Chow, (unknown), Thomas Gridley, Jayaraj Rajagopal	128
10	Yap Tunes Airway Epithelial Size and Architecture by Regulating the Identity, Maintenance, and Self-Renewal of Stem Cells 2014 ·Developmental Cell ·Rui Zhao, Timothy Fallon, Srinivas Vinod Saladi, Ana Pardo–Saganta, Jorge Villoria, Hongmei Mou, Vladimír Vinarský, Meryem Gonzalez-Celeiro, Naveen Nunna, Lida P. Hariri, Fernando D. Camargo, Leif W. Ellisen, Jayaraj Rajagopal	161
11	Airway-Specific Inducible Transgene Expression Using Aerosolized Doxycycline 2013 ·American Journal of Respiratory Cell and Molecular Biology ·Purushothama Rao Tata, Ana Pardo–Saganta, (unknown), Vladimir Vinarsky, Brandon M. Law, Benjamin Fontaine, Andrew M. Tager, Jayaraj Rajagopal	9
12	Dedifferentiation of committed epithelial cells into stem cells in vivo breakdown → 2013 ·Nature ·Purushothama Rao Tata, Hongmei Mou, Ana Pardo–Saganta, Rui Zhao, (unknown), Brandon M. Law, Vladimir Vinarsky, (unknown), Sylvie Breton, Amar Sahay, Benjamin D. Medoff, Jayaraj Rajagopal	499
13	Ciliated Cells of Pseudostratified Airway Epithelium Do Not Become Mucous Cells after Ovalbumin Challenge 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Ana Pardo–Saganta, Brandon M. Law, Meryem Gonzalez-Celeiro, Vladimir Vinarsky, Jayaraj Rajagopal	48
14	In Vivo Imaging of Tracheal Epithelial Cells in Mice during Airway Regeneration 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Jun Ki Kim, Vladimir Vinarsky, John Wain, Rui Zhao, Keehoon Jung, (unknown), Adam Lam, Ana Pardo–Saganta, Sylvie Breton, Jayaraj Rajagopal, Seok Hyun Yun	25
15	The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression 2009 ·Journal of Hepatology ·Ana Pardo–Saganta, María U. Latasa, Josefa Castillo, (unknown), María J. Perugorria, Pablo Sarobe, Carlos M. Rodríguez‐Ortigosa, Jesús Prìeto, Carmen Berasain, Mónica Santamaría, Matías A. Ávila	17
16	Histocompatibility Class I and II Antigens in Extensive Kindred With Sneddon’s Syndrome and Related Hypercoagulation Disorders 2006 ·Human Immunology ·(unknown), Ana Pardo–Saganta, Antonio Arnaiz‐Villena, Adriano Jiménez‐Escrig, (unknown)	2
17	Myelodysplastic syndrome with erythroid hypoplasia/aplasia: A case report and review of the literature 1998 ·American Journal of Hematology ·Julio García‐Suárez, Teresa Pascual, (unknown), Begoña Herrero, Ana Pardo–Saganta	22
18	EBV‐positive non‐Hodgkin's lymphoma developing after phenytoin therapy 1996 ·British Journal of Haematology ·Julio García‐Suárez, (unknown), (unknown), (unknown), (unknown), Miguel Á. Piris, Ana Pardo–Saganta	2
19	Thrombotic Microangiopathic Nephropathy in Scleroderma and Lupus Anticoagulant 1991 ·The Nephron journals/Nephron journals ·C. Quereda, Julio Pascual, Ana Pardo–Saganta, F Mampaso, Ana Gonzalo, J. Ortuño	8
20	Lupus-Like in vitro Anticoagulant Activity in End-Stage Renal Disease 1988 ·The Nephron journals/Nephron journals ·(unknown), Ana Pardo–Saganta, Santiago Lamas, L. Orofıno, (unknown), Roberto Marcén, J.L. Teruel, (unknown)	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact